Trends in disease focus of drug development

Nature Reviews Drug Discovery

Volumn 7, Issue 8, 2008, Pages 639-640

  Karlberg, Johan P E ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; ANTIOBESITY AGENT;

ARTICLE; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DEPRESSION; DIABETES MELLITUS; DRUG INDUSTRY; DRUG RESEARCH; FECES INCONTINENCE; HEALTH CARE COST; HUMAN; HYPERTENSION; INFECTION; MEDICAL RESEARCH; MENTAL DISEASE; NEOPLASM; OBESITY; PREVALENCE; PRIORITY JOURNAL; REGISTER; SCHIZOPHRENIA; TREND STUDY;

CLINICAL TRIALS AS TOPIC; DISEASE; DRUG DESIGN; HUMANS; PHARMACEUTICAL PREPARATIONS; TECHNOLOGY, PHARMACEUTICAL;

EID: 48749122516     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd2618     Document Type: Article

References (11)

1. De Angelis C. et al. Clinical trial registration: A statement from the International Committee of Medical Journal Editors. N. Engl. J. Med. 351, 1250-1251 (2004).
2. De Angelis, C. et al. Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. N. Engl. J. Med. 352, 2436-2438 (2005).
3. Karlberg, J. P. E. Globalization of sponsored clinical trials. Nature Rev. Drug Discov. 1 May 2008 (doi: 10. 1038/nrd2441 -c1).
4. Thiers, F. A., Sinskey, A. J. & Berndt, E. R. Trends in the globalization of clinical trials. Nature Rev. Drug Discov. 7 13-14 (2008).
5. Heron, M. Deaths: Leading causes for 2004. Natl Vital Stat. Rep. 56, 1-96 (2007).
6. IMS Health. Leading Therapy Classes by Global Pharmaceutical sales, 2006. IMS Health web site [online], (2007).
7. US Cancer Statistics Working Group. United States Cancer Statistics: 2004 Incidence and Mortality. [online], (2007).
8. IMS Health. Leading products by Global Pharmaceutical Sales, 2006. IMS Health web site [online], (2007).
9. Narayan, K. M. V. et al. Lifetime risk for diabetes mellitus in the United States. JAMA 290, 1884-1990 (2003).
10. Mokdad, A. H. et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289, 76-79 (2003).
11. Melnikova, I. & Wages, D. Anti-obesity therapies. Nature Rev. Drug Discov. 5, 369-370 (2006).